199 related articles for article (PubMed ID: 22267207)
1. Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution.
Chen PY; Tsai CT; Ou CY; Hsu WT; Jhuo MD; Wu CH; Shih TC; Cheng TH; Chung JG
Mol Med Rep; 2012 Apr; 5(4):1043-8. PubMed ID: 22267207
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and computational studies of Tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and hH3 receptor antagonists.
Darras FH; Pockes S; Huang G; Wehle S; Strasser A; Wittmann HJ; Nimczick M; Sotriffer CA; Decker M
ACS Chem Neurosci; 2014 Mar; 5(3):225-42. PubMed ID: 24422467
[TBL] [Abstract][Full Text] [Related]
3. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
4. Rational design of new multitarget histamine H
Łażewska D; Bajda M; Kaleta M; Zaręba P; Doroz-Płonka A; Siwek A; Alachkar A; Mogilski S; Saad A; Kuder K; Olejarz-Maciej A; Godyń J; Stary D; Sudoł S; Więcek M; Latacz G; Walczak M; Handzlik J; Sadek B; Malawska B; Kieć-Kononowicz K
Eur J Med Chem; 2020 Dec; 207():112743. PubMed ID: 32882609
[TBL] [Abstract][Full Text] [Related]
5. Search for multifunctional agents against Alzheimer's disease among non-imidazole histamine H3 receptor ligands. In vitro and in vivo pharmacological evaluation and computational studies of piperazine derivatives.
Jończyk J; Lodarski K; Staszewski M; Godyń J; Zaręba P; Soukup O; Janockova J; Korabecny J; Sałat K; Malikowska-Racia N; Hebda M; Szałaj N; Filipek B; Walczyński K; Malawska B; Bajda M
Bioorg Chem; 2019 Sep; 90():103084. PubMed ID: 31271942
[TBL] [Abstract][Full Text] [Related]
6. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
[TBL] [Abstract][Full Text] [Related]
7. Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.
Bembenek SD; Keith JM; Letavic MA; Apodaca R; Barbier AJ; Dvorak L; Aluisio L; Miller KL; Lovenberg TW; Carruthers NI
Bioorg Med Chem; 2008 Mar; 16(6):2968-73. PubMed ID: 18249544
[TBL] [Abstract][Full Text] [Related]
8. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
9. Biphenylalkoxyamine Derivatives-Histamine H
Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the histamine H
Lopes FB; Aranha CMSQ; Corrêa MF; Fernandes GAB; Okamoto DN; Simões LPM; Junior NMN; Fernandes JPS
Chem Biol Drug Des; 2022 Nov; 100(5):722-729. PubMed ID: 36050829
[TBL] [Abstract][Full Text] [Related]
13. Multitargeting Histamine H
Łażewska D; Kaleta M; Zaręba P; Godyń J; Dubiel M; Honkisz-Orzechowska E; Doroz-Płonka A; Więckowska A; Stark H; Kieć-Kononowicz K
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903593
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands.
Łażewska D; Jończyk J; Bajda M; Szałaj N; Więckowska A; Panek D; Moore C; Kuder K; Malawska B; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2016 Aug; 26(16):4140-5. PubMed ID: 27445168
[TBL] [Abstract][Full Text] [Related]
15. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
Incerti M; Flammini L; Saccani F; Morini G; Comini M; Coruzzi M; Barocelli E; Ballabeni V; Bertoni S
ChemMedChem; 2010 Jul; 5(7):1143-9. PubMed ID: 20512794
[TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H
Ghamari N; Dastmalchi S; Zarei O; Arias-Montaño JA; Reiner D; Ustun-Alkan F; Stark H; Hamzeh-Mivehroud M
Chem Biol Drug Des; 2020 Feb; 95(2):279-290. PubMed ID: 31661597
[TBL] [Abstract][Full Text] [Related]
17. A molecular approach in drug development for Alzheimer's disease.
Agatonovic-Kustrin S; Kettle C; Morton DW
Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
[TBL] [Abstract][Full Text] [Related]
18. A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease.
Peitzika SC; Pontiki E
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770750
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
da Silva CH; Campo VL; Carvalho I; Taft CA
J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
